ImmuCell Corporation (ICCC)

5.05

0.26 (5.43%)

At close: Apr 01, 2025, 3:59 PM

5.10

0.99%

After-hours: Apr 01, 2025, 04:35 PM EDT

ImmuCell Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-2.16M	-5.77M	-2.49M	-78.29K	-1.02M
Depreciation & Amortization	n/a	n/a	2.49M	2.46M	2.35M
Stock-Based Compensation	326K	n/a	266.24K	144.31K	253.13K
Other Working Capital	n/a	-2.43M	179.9K	-245.49M	-299.61M
Other Non-Cash Items	1.83M	3.37M	28.8K	18.56K	-780.35K
Deferred Income Tax	n/a	n/a	n/a	30.96K	-14.63K
Change in Working Capital	n/a	-2.27M	-1.83M	-1.62M	532.26K
Operating Cash Flow	n/a	-4.67M	-1.54M	954.17K	1.32M
Capital Expenditures	n/a	-1.89M	-3.98M	-2.61M	-4.07M
Acquisitions	n/a	n/a	11K	15.29K	45.6K
Purchase of Investments	n/a	n/a	n/a	-15.29K	-1.99M
Sales Maturities Of Investments	n/a	n/a	n/a	996K	3.45M
Other Investing Acitivies	n/a	2.47K	11K	15.29K	45.6K
Investing Cash Flow	n/a	-1.89M	-3.96M	-1.6M	-2.57M
Debt Repayment	n/a	1.81M	1.1M	-368.27K	1.96M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-62.77K	11.36K	13.96K	-53.13K
Financial Cash Flow	n/a	1.75M	1.11M	3.88M	1.91M
Net Cash Flow	-978.74K	-4.81M	-4.39M	3.24M	656.64K
Free Cash Flow	n/a	-6.57M	-5.52M	-1.65M	-2.76M